Information Provided By:
Fly News Breaks for April 13, 2015
ABBV
Apr 13, 2015 | 08:34 EDT
As noted earlier, BMO Capital upgraded AbbVie to Outperform from Market Perform. The firm now believes that Imbruvica sales can almost completely offset the expected decline in Humira sales. Target to $68 from $60.